Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report

INTRODUCTION: Papillary renal cell carcinoma (PRCC), which represents around 20% of renal cell carcinomas, is a heterogeneous disease that includes different tumor types with several clinical and molecular phenotypes. Nivolumab, a fully human IgG4 programed cell death protein 1 immune checkpoint inh...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Ruiz-Bañobre, Juan, Anido, Urbano, Abdulkader, Ihab, Antúnez-López, José, López-López, Rafael, García-González, Jorge
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2016
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118772/
https://ncbi.nlm.nih.gov/pubmed/27921007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00250
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker